Gopi Shankar insider trades
Open-market stock purchases and sales by Gopi Shankar, Chief Development Officer at Larimar Therapeutics, Inc, from SEC Form 4 filings since Feb 7, 2023.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -39%.
Companies traded
- LRMR Larimar Therapeutics, Inc: 1 buy, last Jan 26, 2026